digital health investment
OneCell Diagnostics scores $16 million for genomics-based precision oncology and dannce.ai, a phenotyping platform to digitize clinical assessments, secures $2.6 million.
The funding includes $4.5 billion for the firm's core VC funds, $1.5 billion for its Creation strategy and $2 billion for separately managed accounts.
The company will use the funds to launch its diagnostics division and expand its offerings under the helm of its new chief operating officer.
Ben Robbins, general partner at GV, wraps up MobiHealthNews' investment series by unveiling the crucial traits digital health companies must possess to secure funding in a highly competitive market.
Brigham Hyde, CEO of Atropos Health, provides the vendor perspective on digital health funding and pitching to venture capitalists in an ever-changing market.
Sonny Shergill, vice president of commercial digital health at AstraZeneca, highlights pharma's perspective on digital health investments and partnerships for sector growth.
Matt Cybulsky, LBMC practice leader for healthcare AI, value-based care and product innovation, discusses consulting digital health companies on seeking investment.
If investment patterns in the first half of 2024 persist, this year could exceed year-end totals seen in 2019 and 2023, according to Rock Health's H1 2024 digital health funding report.
A GSR Ventures survey revealed 71% of investors believe the tech is changing their investment strategy "somewhat," and 17% say it changes their strategy "significantly."
A GSR Ventures survey of 50 investors reveals return on investment and clinical validation would be vital to a company's success next year.